Tokyo, Aug. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058749) titled 'Prospective Study on Treatment Outcomes and Quality of Life Improvement in Lymphedema and Other Lymphatic Disorders' on Aug. 9.
Study Type:
Observational
Primary Sponsor:
Institute - Mukumi Clinic
Condition:
Condition - Lymphedema and Other Lymphatic Disorders
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To prospectively evaluate clinical outcomes in patients with lymphedema and other lymphatic disorders, and to assess the usefulness and validity of our diagnostic and therapeutic approaches.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who visited the outpatient clinic of Mukumi Clinic between April 1, 2025, and March 31, 2030, and were diagnosed with lymphedema or other lymphatic disorders, who meet the following conditions:
Provided signed consent regarding academic presentations and publications at the time of the first visit to Mukumi Clinic or equivalent.
Underwent examination, treatment, or surgery at Mukumi Clinic during the study period.
Key exclusion criteria - Patients deemed unsuitable for inclusion in the study by the principal investigator.
Patients who declined to participate in the study.
Target Size - 1000
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 04 Month 01 Day
Date of IRB - 2025 Year 07 Month 15 Day
Anticipated trial start date - 2025 Year 04 Month 01 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067175
Disclaimer: Curated by HT Syndication.
